n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with zileuton in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbey, S; Charlier, C; Choesmel, V; Cornet, J; Gimeno, G; Goossens, L; Hénichart, JP; Houssin, R; Michaux, C; Rouaud, C; Taverne, T; Yannic-Arnoult, S | 1 |
| Adams, M; Bauer, R; Bodensieck, A; Haslinger, E; Hüfner, A; Kunert, O; Oluwemimo, A; Pferschy-Wenzig, EM; Prettner, E; Schühly, W | 1 |
| Cai, XH; Feng, T; Gong, X; Li, Y; Liu, YP; Luo, XD; Tan, QG; Zhang, RT; Zhang, XY | 1 |
| Aparoy, P; Chandramohan Reddy, T; Kalangi, SK; Kumar Reddy, K; Reddanna, P | 1 |
| Bauer, R; Blunder, M; Fabian, WM; Hüfner, A; Kunert, O; Pferschy-Wenzig, EM; Saf, R; Schühly, W | 1 |
| Atanasov, AG; Bauer, J; Bauer, R; Baumgartner, L; Bodensieck, A; Dirsch, VM; Fakhrudin, N; Favero, GD; Heiss, EH; Ladurner, A; Loggia, RD; Ponti, C; Rollinger, JM; Schwaiger, S; Sosa, S; Stuppner, H; Tubaro, A; Werz, O; Widowitz, U | 1 |
| Alcaraz, MJ; Guillén, MI; Vicente, AM | 1 |
7 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and zileuton
| Article | Year |
|---|---|
Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor.
Topics: Animals; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Granulocytes; Inhibitory Concentration 50; Isoenzymes; Lipoxygenase Inhibitors; Male; Monocytes; Osteosarcoma; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Structure-Activity Relationship; Sulfones | 2002 |
Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.
Topics: Arachidonate 5-Lipoxygenase; Biphenyl Compounds; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Humans; Leukocytes; Leukotriene B4; Lignans; Magnolia; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2009 |
Monoterpenoid indole alkaloids from Alstonia yunnanensis.
Topics: Alstonia; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Secologanin Tryptamine Alkaloids | 2009 |
Pharmacophore modeling and virtual screening for designing potential 5-lipoxygenase inhibitors.
Topics: Arachidonate 5-Lipoxygenase; Computer Simulation; Drug Design; Drug Evaluation, Preclinical; Lipoxygenase Inhibitors; Models, Chemical; Models, Molecular | 2010 |
Derivatives of schisandrin with increased inhibitory potential on prostaglandin E(2) and leukotriene B(4) formation in vitro.
Topics: Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Circular Dichroism; Cyclooctanes; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Indicators and Reagents; Leukotriene B4; Lignans; Lipoxygenase Inhibitors; Magnetic Resonance Spectroscopy; Polycyclic Compounds; Schisandra; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2010 |
Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and pro-inflammatory mediators in vitro.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Austria; Benzofurans; Cyclooxygenase 1; Edema; Intramolecular Oxidoreductases; Krameriaceae; Lignans; Male; Mice; NF-kappa B; Plant Roots; Prostaglandin-E Synthases | 2011 |
Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages.
Topics: Amidines; Animals; Benzylamines; Cell Line; Chick Embryo; Cyclooxygenase 2; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hydroxyurea; Indomethacin; Isoenzymes; Leukotriene B4; Leukotriene C4; Leukotrienes; Macrophage Activation; Macrophages; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Protein Binding; Pyrans; Quinolones; Sulfonamides; Time Factors; Transcription Factor AP-1; Zymosan | 2001 |